IBOV 175,664.62 ▲ 0.30% IPSA 11,445.90 ▼ 0.22% IPC MEX 65,484.32 ▼ 0.53% MERVAL 2,979,472 ▼ 0.72% COLCAP 2,457.87 ▼ 1.28% BVL PERÚ 60,779.49 ▼ 1.40% USD/BRL5.19▼ 0.01% USD/MXN17.03▼ 0.02% USD/CLP930.58— 0.00% USD/COP3,202▲ 1.26% USD/PEN3.35▼ 0.01% USD/ARS1,512— 0.00% USD/UYU40.27▲ 1.47% USD/PYG5,900▲ 1.27% USD/BOB11.78▲ 3.30% USD/DOP58.61▲ 0.96% USD/CRC446.65▲ 0.97% USD/GTQ7.62▲ 2.20% USD/HNL26.84▲ 0.40% USD/NIO36.62— 0.00% USD/VES789.69▼ 0.54% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.72▲ 0.84% EUR/BRL6.01▲ 0.17% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 175,664.62 ▲ 0.30% IPSA 11,445.90 ▼ 0.22% IPC MEX 65,484.32 ▼ 0.53% MERVAL 2,979,472 ▼ 0.72% COLCAP 2,457.87 ▼ 1.28% BVL PERÚ 60,779.49 ▼ 1.40% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Sunday, August 30, 2026

Covid-19 Brazil

Two years late: Pfizer and Moderna launch research to determine links between Covid vaccine and myocarditis

By · November 16, 2022 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

After two years of inaction and distributing the vaccines with emergency authorizations that allowed them not to do this type of study, the Pfizer and Moderna laboratories finally announced the launch of a clinical investigation into the links between their Covid vaccines and the heart problems.

The Federal Food and Drug Administration (FDA) determined in October last year that myocarditis may be a side effect of vaccines based on mRNA technology, and asked the two largest companies in the United States to carry out a study to answer this question.

According to NBC, “Moderna has already launched two essays, the most recent in September. Pfizer confirmed that at least one of its trials, which will include up to 500 adolescents and young adults under the age of 21, is scheduled to begin in the next two months.”

Private studies in both the United States and Israel linked the Pfizer-BioNTech and Moderna vaccine to rare cases of myocarditis, looking at the highest level of risk in men ages 16 to 29 (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

There is a broad consensus that the benefits of the vaccine in older adults outweigh the risks of the adverse effects that they entail. However, since the strategy of practically all the governments of the world was to vaccinate the entire population on a mandatory basis, it has now been called into question how widespread heart disease has become in young adults and adolescents.

Reports of myocarditis as a side effect of the Covid vaccine emerged almost immediately after the vaccine launches and persisted until 2022. But for some uncertain reason social media and the media prevented this news from breaking out.

Private studies in both the United States and Israel linked the Pfizer-BioNTech and Moderna vaccine to rare cases of myocarditis, looking at the highest level of risk in men ages 16 to 29.

It should be clarified that questioning vaccination in healthy children under 30 years of age had become a crime in the United States and other countries around the world, with several cases of people who lost their jobs, or doctors their registration, for making these statements.

For the FDA to fully approve any vaccine, it requires companies to conduct several types of studies, some of which are planned to last 5 years. All of this was bypassed and both vaccines received emergency approval in 2020.

This would not be a problem if the vaccine were optional: anyone who wants to receive an experimental vaccine without the corresponding clinical trials should be able to do so. But the global decision against the coronavirus was to vaccinate all people against their will, and those who did not lose their civil rights, thanks to the unconstitutional health passes.

Finally, it is important to clarify for those who are still skeptical that the CDC has officially designated myocarditis as an adverse effect of the vaccine in men between the ages of 16 and 24. On its government page, more than 1,000 official cases have been reported as a side effect of the vaccine.

With information from Derecha Diario

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.